Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations
- PMID: 32363244
- PMCID: PMC7194663
- DOI: 10.1016/j.adro.2020.03.011
Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations
References
-
- Ferguson N.M., Laydon D., Nedjati-gilani G. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-... Available at: Accessed March 21, 2020. - PMC - PubMed
-
- Whelan T.J., Pignol J.-P., Levine M.N. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–520. - PubMed
-
- Moran M.S., Truong P.T. Hypofractionated radiation treatment for breast cancer: The time is now. Breast J. 2020;26:47–54. - PubMed
-
- Whelan T.J., Julian J.A., Berrang T.S. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial. Lancet. 2019;394:2165–2172. - PubMed
LinkOut - more resources
Full Text Sources